Co-Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Co-Diagnostics and other ETFs, options, and stocks.

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. 

CEO
Dwight Howard Egan
CEODwight Howard Egan
Employees
115
Employees115
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
115
Employees115

CODX Key Statistics

Market cap
4.08M
Market cap4.08M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
—
Dividend yield—
Average volume
443.76K
Average volume443.76K
High today
$0.649
High today$0.649
Low today
$0.512
Low today$0.512
Open price
$0.5494
Open price$0.5494
Volume
549.35K
Volume549.35K
52 Week high
$46.50
52 Week high$46.50
52 Week low
$0.512
52 Week low$0.512

Stock Snapshot

Co-Diagnostics(CODX) stock is priced at $0.54, giving the company a market capitalization of 4.08M. It carries a P/E multiple of -0.02.

On 2026-10-27, Co-Diagnostics(CODX) stock moved within a range of $0.51 to $0.65. With shares now at $0.54, the stock is trading +5.6% above its intraday low and -16.7% below the session's peak.

Trading volume for Co-Diagnostics(CODX) stock has reached 549.35K, versus its average volume of 443.76K.

Over the past 52 weeks, Co-Diagnostics(CODX) stock has traded between a high of $46.50 and a low of $0.51.

Over the past 52 weeks, Co-Diagnostics(CODX) stock has traded between a high of $46.50 and a low of $0.51.

CODX News

Benzinga 48m
EXCLUSIVE: Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India

Co-Diagnostics Inc. (NASDAQ:CODX) said on Tuesday that it moved closer to launching its point-of-care tuberculosis testing technology in South Asia after its jo...

EXCLUSIVE: Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India

People also own

Based on the portfolios of people who own CODX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.